Acceleration Therapeutics' AT-101 Reclassified by FDA

Acceleration Therapeutics Division of Non-Invasive Monitoring Systems announced that the FDA reclassified the flagship product of the company, the AT-101 device, from its listed FDA Class 1 (exempt) powered exercise device to a therapeutic vibrator requiring 510(k) submission.

Yahoo News (http://biz.yahoo.com/bw/050124/245445_1.html)